IMPACT OF PEGYLATED INTERFERON α2B PLUS RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Ogawa, E. [1 ]
Furusyo, N. [1 ]
Kajiwara, E. [1 ]
Takahashi, K. [1 ]
Nomura, H. [1 ]
Tanabe, Y. [1 ]
Satoh, T. [1 ]
Maruyama, T. [1 ]
Nakamuta, M. [1 ]
Kotoh, K. [1 ]
Azuma, K. [1 ]
Dohmen, K. [1 ]
Shimoda, S. [1 ]
Hayashi, J. [1 ]
机构：
[1] Kyushu Univ, Liver Dis Study KULDS Grp, Fukuoka 812, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1145
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [41] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [42] Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
    Giulia Malaguarnera
    Gaetano Bertino
    Carmela Greco
    Caterina Gagliano
    Massimo Motta
    Giuseppe Chisari
    Venerando Rapisarda
    Giuseppe Nunnari
    Michele Vecchio
    Filippo Drago
    Michele Malaguarnera
    Translational Medicine Communications, 2 (1)
  • [43] Sustained viral response to pegylated interferon α-2b and ribavirin in chronic hepatitis C refractory to prior treatment
    Mathew, A.
    Peiffer, L. P.
    Rhoades, K.
    McGarrity, T.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (11) : 1956 - 1961
  • [44] Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment
    A. Mathew
    L. P. Peiffer
    K. Rhoades
    T. McGarrity
    Digestive Diseases and Sciences, 2006, 51 : 1956 - 1961
  • [45] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    GUT, 2003, 52 (10) : 1532 - 1532
  • [46] Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C
    Iwona Mozer-Lisewska
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 316 - 317
  • [47] Triple combination of pegylated interferon alpha 2b, ribavirin and amantadine for treatment of chronic hepatitis
    Younossi, ZM
    McCullough, AJ
    Barnes, DS
    Post, A
    Ong, JP
    Mullen, KD
    Carey, WD
    O'Shea, R
    Levinthal, G
    Gramlich, T
    Martin, LM
    Bringman, D
    Tavill, A
    Ferguson, R
    GASTROENTEROLOGY, 2003, 124 (04) : A781 - A781
  • [48] Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in HIV-infected patients
    Romero, M
    Perez-Olmeda, M
    Garcia-Samaniego, J
    Gonzalez, J
    Castro, A
    Arribas, JR
    Pedreira, J
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2002, 36 : 107 - 107
  • [49] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
  • [50] Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?
    Floreani, A
    Minola, E
    Carderi, I
    Ferrara, F
    Rizzotto, ER
    Baldo, V
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (03) : 549 - 550
12345